Publication | Closed Access

Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson’s disease

Neurodegenerative DiseasesDementiaParkinson ’NeurologyMedicineTreatmentGeriatric NeurologyLewy Body Dementia